Possible Prognostic Role of BMI Before Chemotherapy in the Outcomes of Women with Ovarian Cancer.

Nutrients · 2025 · PMC11820758 · PMID 39940415

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In contrast, other studies showed a trend towards improved survival in ovarian cancer patients with BMI ≥ 25 [ 16 , 17 ], while BMI reduction during or after chemotherapy was linked to poorer outcomes [ 18 , 19 , 20 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.